Literature DB >> 32488291

Where have all the hip fractures gone?

K C Wong1, J W G Cheok2, K X K Tay2, S B Koh2, T S Howe2.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32488291      PMCID: PMC7266647          DOI: 10.1007/s00198-020-05483-0

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   5.071


× No keyword cloud information.
Dear Editor, Amidst the coronavirus disease 2019 (COVID-19) pandemic, we have noticed a marked unexplained decrease in osteoporotic hip fracture surgeries in our institution. This is baffling and mirrors the unexplained reported decrease in heart attacks and strokes [1]. We also looked at time to surgery to see if our protocols during COVID-19 had compromised fracture care. Singapore’s Disease Outbreak Response System Condition (DORSCON) status escalated to Orange [2] in response to worsening community spread. Resource and manpower considerations affected all departments in our institution including the Department of Orthopedic Surgery [3]. This prompted an investigation into the quality of care afforded to hip fracture patients during the COVID-19 pandemic. We hypothesized that a well-executed treatment protocol ensures that care afforded to hip fracture patients should remain unaffected. We compared surgically managed hip fracture patients admitted 2 months before escalation to DORSCON Orange (“pre-COVID”), with patients admitted 2 months after (“post-COVID”). Indications for hip fracture surgery remain unchanged. We collected demographic data, time taken to be admitted to ward from the Emergency Department, as well as time elapsed between ward admission and surgery. We found a sharp decrease in hip fractures during the COVID-19 pandemic, with 76 pre-COVID patients compared with 35 post-COVID patients (54% decrease). There were no differences in demographic data, time to admission (2.0 ± 1.2 versus 1.7 ± 0.9; mean difference, 0.3; 95% CI, − 0.2 to 0.7; p = 0.20), and time to surgery (60.7 ± 45.1 versus 45.0 ± 42.3; mean difference, 15.7; 95% CI, − 2.2 to 33.6; p = 0.084) between both cohorts (Table 1).
Table 1

Demographic data and treatment protocol parameters

Pre-COVID (n = 76)Post-COVID (n = 35)p value
Gender (female:male)44:3222:13p = 0.621
Age (years)79.6 ± 8.576.3 ± 8.4p = 0.059
ASA class (n)p = 0.483
  II3118
  III4417
  IV10
Time to ward (hours)2.0 ± 1.21.7 ± 0.9p = 0.200
Time to surgery (hours)60.7 ± 45.145.0 ± 42.3p = 0.084
Demographic data and treatment protocol parameters Our study population is a bellwether of orthopedic trauma care as most osteoporotic hip fractures are now treated surgically due to benefits of reduced length of hospital stay and improved rehabilitation [4]. In Singapore, emergency services have defined evacuation protocols to identified public hospitals. As the vast majority of hip fractures usually require emergency services for delivery to hospitals, which has not changed from the pre-COVID era, the proportion of hip fracture patients brought to our institution should not have changed. A similar pattern was noticed in myocardial infarctions in the USA where up to a 60% reduction in admissions was reported, postulated to be due to COVID-19 instilling a fear of face-to-face medical care as people would rather stay at home than risk seeking treatment [1]. With the need for additional perioperative precautions during this pandemic [5], detrimental effects on the ability of an overwhelmed healthcare system to provide timely hip fracture care is understandable, evident in increased delay in time to surgery [6]. However, despite the implementation of department segregation protocols which disrupt routine workflow, there was no delay in time to admission and surgery in our study population. This suggests that an established bundled care protocol for hip fractures can withstand the challenges during a pandemic and ensure that the standard of care is not compromised. Will we eventually see patients with late sequelae of untreated fractures? Is treatment being compromised, leading to poorer functional performance and quality of life? Further studies will be essential in evaluating the downstream effects on patients with hip fractures. The question of whether there will be a rebound in osteoporotic hip fractures after the current COVID crisis is over remains unanswered, but we should plan for this eventuality.
  3 in total

Review 1.  Conservative versus operative treatment for hip fractures in adults.

Authors:  Helen H G Handoll; Martyn J Parker
Journal:  Cochrane Database Syst Rev       Date:  2008-07-16

2.  Ensuring Business Continuity of Musculoskeletal Care During the COVID-19 Pandemic: Experience of a Tertiary Orthopaedic Surgery Department in Singapore.

Authors:  Ming Han Lincoln Liow; Kenny Xian Khing Tay; Nicholas Eng Meng Yeo; Darren Keng Jin Tay; Seo Kiat Goh; Joyce Suang Bee Koh; Tet Sen Howe; Andrew Hwee Chye Tan
Journal:  JB JS Open Access       Date:  2020-05-15

Review 3.  Perioperative Considerations in Urgent Surgical Care of Suspected and Confirmed COVID-19 Orthopaedic Patients: Operating Room Protocols and Recommendations in the Current COVID-19 Pandemic.

Authors:  Mohamed E Awad; Jacob C L Rumley; Jose A Vazquez; John G Devine
Journal:  J Am Acad Orthop Surg       Date:  2020-06-01       Impact factor: 3.020

  3 in total
  7 in total

Review 1.  One Year on: An Overview of Singapore's Response to COVID-19-What We Did, How We Fared, How We Can Move Forward.

Authors:  S Vivek Anand; Yao Kang Shuy; Poay Sian Sabrina Lee; Eng Sing Lee
Journal:  Int J Environ Res Public Health       Date:  2021-08-30       Impact factor: 4.614

2.  Timeout? The Epidemiology of Pediatric Sports Injuries During the COVID-19 Pandemic.

Authors:  Jacob T Wild; Yash V Kamani; John M Bryan; Taylor N Hartman; Lauren M Spirov; Neeraj M Patel
Journal:  J Am Acad Orthop Surg Glob Res Rev       Date:  2022-04-08

3.  Outcomes of COVID-19 Negative Hip Fracture Patients During the Acute and Subacute Pandemic.

Authors:  Naoko Onizuka; Lauren N Topor; Lisa K Schroder; Julie A Switzer
Journal:  Geriatr Orthop Surg Rehabil       Date:  2021-03-31

4.  Mortality escalates in patients of proximal femoral fractures with COVID-19: A systematic review and meta-analysis of 35 studies on 4255 patients.

Authors:  Mohit Kumar Patralekh; Vijay Kumar Jain; Karthikeyan P Iyengar; Gaurav Kumar Upadhyaya; Raju Vaishya
Journal:  J Clin Orthop Trauma       Date:  2021-04-20

5.  Reduction prevalence of fragility fracture hospitalisation during the COVID-19 lockdown.

Authors:  Philipe de Souto Barreto; Didier Fabre; Bruno Vellas; Hubert Blain; Laurent Molinier; Yves Rolland
Journal:  Arch Osteoporos       Date:  2022-04-18       Impact factor: 2.617

6.  Human umbilical cord mesenchymal stromal cells promotes the proliferation and osteogenic differentiation of autologous bone marrow stem cells by secreting exosomes.

Authors:  Yao Hai; Cao Zhidong; Wu Wenyan
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

7.  Surgical treatment for fragility hip fractures during the COVID-19 pandemic resulted in lower short-term postoperative functional outcome and a higher complication rate compared to the pre-pandemic period.

Authors:  Chirathit Anusitviwat; Ekasame Vanitcharoenkul; Pojchong Chotiyarnwong; Aasis Unnanuntana
Journal:  Osteoporos Int       Date:  2022-07-09       Impact factor: 5.071

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.